Zepp Health (ZEPP) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Zepp Health Corporation faced a 56% revenue decline in the second quarter of 2024 compared to the previous year, reporting $40.6 million in revenue and a significant drop in units shipped. Despite this, the company achieved a record-high gross margin of 40.3%, driven by a strategic focus on self-branded products and a reduction in clearance sales. The firm anticipates continued gross margin improvement and is preparing to launch new AI-integrated products in the wearable tech market.
For further insights into ZEPP stock, check out TipRanks’ Stock Analysis page.
